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Background
GPR55 was recently found to be a novel cannabinoid
receptor containing a seven transmembrane-spanning
domain and being a member of the G protein-coupled
receptor (GPCR) subfamily A. GPR55 is activated by dif-
ferent cannabinoid ligands as well as by the lipid ligand
lysophosphatidylinositol (LPI). Generally, the activity of
GPCRs is coordinated by receptor signaling, receptor
desensitization and receptor resensitization. The latter
two mechanisms are typically associated with the sorting
of the GPCRs between degradation or recycling pathways
and are highly regulated. Several sorting proteins have
recently been identified, for example the G protein-cou-
pled receptor-associated sorting protein-1 (GASP1).
GASP1 was originally found to target δ opioid receptors
(DORs) to lysosomes, hence a degradative pathway.
Moreover, it was shown that the interface of the DOR-
GASP1 protein-protein interaction is predominantly
located in the C-terminal portion of the receptor protein.
Results
Here we show that the novel cannabinoid receptor GPR55
can internalize after ligand activation and is subsequently
targeted to intracellular vesicles of the lysosomal compart-
ments. This result and the close similarity of GPR55 to the
cannabinoid receptor CB1 - which is targeted to lysosomes
via the GASP1 protein - suggested that GASP may be
involved in targeting GPR55 to lysosomes. In fact, the C-
terminus of GPR55 binds GASP1, cGASP1 (the C-terminal
part of GASP1) and GASP2 (the closest homologue to
GASP1) in vitro.
Conclusion
This work provides the first evidence that the novel can-
nabinoid receptor GPR55 is targeted to lysosomes after
prolonged agonist stimulation and that this mechanism is
likely regulated by members of the newly discovered G
protein-coupled receptor-associated sorting proteins, i.e
GASP1 and GASP2.
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